Disorders of sphingolipid metabolism and other lipid storage disorders
Notes: Adult GM2 gangliosidosis ; Juvenile GM2 gangliosidosis ; Gangliosidosis NOS ; GM1 gangliosidosis ; GM3 gangliosidosis ; Acid sphingomyelinase deficiency (ASMD) ; Acid sphingomyelinase deficiency type A (ASMD type A) ; Infantile neurovisceral acid sphingomyelinase deficiency ; Acid sphingomyelinase deficiency type B (ASMD type B) ; Chronic visceral acid sphingomyelinase deficiency ; Acid sphingomyelinase deficiency type A/B (ASMD type A/B) ; Chronic neurovisceral acid sphingomyelinase deficiency ; Acid sphingomyelinase deficiency (ASMD) NOS ; Multiple sulfatase deficiency (MSD) ; Farber’s syndrome ; Sulfatide lipidosis ; Batten disease ; Bielschowsky-Jansky disease ; Kufs disease ; Spielmeyer-Vogt disease ; Cerebrotendinous cholesterosis [van Bogaert-Scherer-Epstein] ; Wolman’s disease ; mucolipidosis, types I-III (E77.0-E77.1) ; Refsum’s disease (G60.1) ; adrenoleukodystrophy [Addison-Schilder] (E71.528)
Post COVID-19 condition, unspecified Notes: Post-acute sequela of COVID-19 ; the specific condition related to…
Post COVID-19 condition Notes: Post-acute sequela of COVID-19 ; the specific condition related to COVID-19…
COVID-19 Notes: code to identify pneumonia or other manifestations, such as: ; pneumonia due to…
Vaping-related disorder Notes: Dabbing related lung damage ; Dabbing related lung injury ; E-cigarette, or…
Emergency use of U07 Notes: Dabbing related lung damage ; Dabbing related lung injury ;…
Dependence on other enabling machines and devices Notes: Dependence on machine or device NOS